Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00191139 · COMPLETED
Trial details
- NCT number
- NCT00191139
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2008-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.